When paired with BPC-157, we think of glutathione as a detoxifier
2Clinically significant [see Dosage and Administration (2) and Warnings and Precautions (5)] 3Mean ratio with 90% CI (with/without coadministered drug, e.g., 1= no change, 0.7 = 30% decrease, 11=11-fold increase in exposure) Table 9: Effect of Rosuvastatin Coadministration on Systemic Exposure to Other Drugs EE = ethinyl estradiol, NG = norgestrel, QD= Once daily 1 Clinically significant pharmacodynamic effects [see Drug Interactions (7.3)] 2Mean ratio with 90% CI (with/without coadministered drug, e.g., 1= no change, 0.7=30% decrease, 11=11-fold increase in exposure) Disposition of rosuvastatin, involves OATP1B1 and other transporter proteins
These side effects are usually mild to moderate and often decrease over time.
Running retatrutide after completing a semaglutide or tirzepatide protocol If you have completed a full semaglutide or tirzepatide protocol and are starting retatrutide as a new treatment after a break, the standard dose schedule applies without modification
It might be sending them a nice note, whatever the case may be
